After public outcry, Publix announced that it is changing its policy to cover PrEP (pre-exposure prophylaxis) in its employee insurance plan.
Gilead Sciences is coming under fire from HIV/AIDS activist groups for a recent change to its patient assistance program, imposing a once-per-lifetime limit on access to Truvada as part of non-occupational post-exposure prophylaxis (nPEP).
A provider in Atlanta says one of his patients employed by the large grocery store chain was denied insurance coverage for pre-exposure prophylaxis (PrEP) coverage, a method for preventing HIV transmission. Is their decision based on cost or conserva...
Betty Price's comments about HIV spark backlash while her committee quietly issues a well-reasoned critique of Georgia's HIV criminal laws.
What are microbicides, why do we need them, and what is the status of current microbicide research? This fact sheet answers those questions and more.
Why is it only some viruses are transmissible by blood, and how does the virus actually move from person to person?
"We cannot end HIV without acknowledging an inconvenient truth: the HIV and STD epidemics are inextricably linked and without combatting both, we won't end HIV," writes National Coalition of STD Directors executive director David Harvey.
This 2017 Biomedical Prevention Conference in New Orleans focused less on the future of HIV prevention tools and more on issues preventing communities most in need from accessing PrEP.
A recent webinar hosted by Positive Women's Network gives some information on how being virally supressed impacts sex, reproductive health, and stigma for women.
Research indicates that robust universal health coverage could contribute to reducing HIV incidence by improving access to proven tools for reducing transmission.